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We present a model to plan a rational strategy for cancer prevention that has two main functions-assessment and intervention. The assessment
function includes three main components: to identify populations at high cancer risk, which may be due to their ethnic group, occupational and
environmental exposures, family history, cigarette smoking, or other risk factors; to assess exposure to known carcinogens through the general and
occupational environments, lifestyle factors, and the home as well as to document known carcinogens using human tissue banks and develop and
validate questionnaires to target known risk factors for each of the most common cancers; and to conduct research studies of high-risk populations,
including studies on mechanism and genetic testing. The intervention function includes three components: development of population-based
intervention programs using the results from the research studies; evaluation of intervention programs; and modification of existing intervention
programs and implementation of new ones. The above-proposed prevention strategy depends to a great extent on population-based cancer
registries. Existing cancer registries around the United States should be strengthened and other dimensions should be added to their charge to
augment their function in prevention research. To convert existing population-based cancer registries, particularly those that serve multiethnic and
multicultural populations, into Cancer Prevention Research Registries (CPRRs), three types of data in addition to their existing required data
complement should be incorporated. These are exposure information including occupational history, host factors information, and information about
family history of cancer and associated conditions. The primary goal of the CPRRs should be to support cancer prevention research in its widest
sense. Future research needs must be designed to investigate each of the components of the prevention strategy as well as its integrated
performance. Regardless of what we do in the future, we must now promote healthier lifestyles, prevent exposure to known carcinogens, and
improve early detection procedures. - Environ Health Perspect 103(Suppl 8):237-239 (1995)
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Introduction
Despite the increasing trends in cancer
incidence rates reported by several studies
(1,2), particularly for cancers ofthe breast,
prostate, lung, and malignant melanoma, it
is clear that the mortality rates for these
cancers have not changed significantly over
time. The increasing incidence of both
breast and prostate cancers is attributed to
better screening and early detection, lung
cancer to increased cigarette smoking, and
malignant melanoma to increased exposure
to sunlight. There are many examples of
strong associations between preventable
causes and specific types of cancer (3-6).
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Thus, in addition to seeking better treat-
ment modalities for cancer patients and
improving knowledge about biological
mechanisms in carcinogenesis, a concerted
effort must be devoted to prevention
strategies and screening programs. In the
long run, this approach will lead to reduc-
tion in the incidence of and the mortality
due to cancer.
To plan a rational strategy for cancer
prevention, one should determine the mag-
nitude of the problem (i.e., the amount of
preventable cancer in a population).
However, the magnitude of preventable
cancer associated with exposure to environ-
mental contaminants in air, soil, water,
and the home is difficult to determine. As a
part ofprevention research, it is imperative
that we identify populations at risk and
their associated exposures. Models that
describe the etiology and mechanism of
carcinogenesis will help establish exposure
associations and direct prevention research.
Studies ofcancer attributed to different
environmental carcinogenic factors are
complex and require the involvement of
several disciplines in science and medicine.
One ofthe main problems in planning and
conducting these studies is the selection of
study populations, since subjects are highly
heterogeneous with respect to their level of
cancer risk. In other words, a population
included in a study may include groups at
high risk for cancer together with groups at
much lower risk, which can result in
inconclusive outcomes (7).
Strategy for Prevention
We propose the model outlined in Figure
1 as a strategy for cancer prevention.
A description of the five components
constituting this model is included in the
following discussion.
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Figure 1. Strategy for prevention.
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IdentifyPopulations atHigh Risk
Groups at high cancer risk may include
special occupational groups, those who have
heritable cancer syndromes, and, possibly
those who because oftheir cultural-ethnic
backgrounds are predisposed to specific
cancers due to diet or lifestyle factors. These
high-risk groups do not necessarily repre-
sent the general population but are ideal for
a first-step study in cancer prevention and
early detection. Cancer registries, particu-
larly those that capture data on risk factors
such as family history, occupation, and
industry, are ideal for monitoring incidence
and prevalence ofcancer in subpopulations
to identify groups at high cancer risk.
ExposureAssessment
Several data sources should be generated
or, ifexisting, should be made available to
scientists, including: a) monitoring over
time the types and levels ofknown carcino-
gens in air, water, soil, food, and the home;
b) documenting and tracking the types and
levels ofchemical carcinogens in commu-
nities impacted by hazardous waste sites
and environmental accidents such as chem-
ical spills; c) documenting existing data on
levels ofknown carcinogens using human
tissue banks such as the national adipose
tissue repository, and improving the qual-
ity of human tissue banks, the accuracy
and sensitivity as well as the collection of
sufficient tissue, and demographic and
medical information on subjects from
whom the tissue is collected; and d) devel-
oping and validating questionnaires to tar-
get known risk factors for each ofthe most
common cancers to be used by investigators
in population studies. This will prevent
duplication ofeffort and expense in devel-
oping new questionnaires for each study,
and will allow comparisons between studies
as well as pooling of data if desired and
appropriate for reasons such as improving
the sample size.
ResearhStudies of
High-RiskPopulations
This is one ofthe most important compo-
nents ofthe strategy for cancer prevention.
Research findings from these studies will
then allow us to: a) estimate the propor-
tion ofavoidable cancer; b) identify groups
in which prevention can be most effective;
c) determine which cancers pose the most
significant public health problem; d) evalu-
ate the effectiveness of prevention trials;
e) evaluate the acceptability of specific
intervention programs-such as gene test-
ing for breast and colorectal cancer-that
are candidates to be made available to
the population at large; f) determine a
possible mechanism for cancer etiology;
g) evaluate dose-response relationships for
both carcinogenic and protective agents;
and h) identify risk factors specific for
particular tumors.
Population-Based
Intervention Programs
Using the results from the research studies
described above, intervention programs
may become feasible and may have high
probabilities ofsuccess. Such intervention
programs may include education and
health promotion; control ofexposure to
known carcinogens in industry, the general
environment, and the home; and imple-
mentation ofpopulation-based chemopre-
vention, early detection programs, genetic
testing, and gene therapy trials.
Evaluation ofIntervention Programs
The evaluation phase of the strategy for
prevention should focus on two main com-
ponents: measures of reduction in risk
using cancer incidence rates and stage at
diagnosis and measures ofhealthier life-
styles, and prevention and early detection
practices in the population.
Modifying ofExisting Programs
and Implementing New Ones
Based on evaluation results and the close
monitoring of population parameters,
intervention programs may either con-
tinue, be modified to improve performance
and results, or be discontinued. This
process is also influenced by new scientific
Existing
communitybased
chemoprwevntion N
trials
findings and the availability of new,
perhaps more efficient, less costly or more
acceptable programs.
Cancer Prevention
Research Registries
The proposed prevention strategy depends
to a great extent on population-based can-
cer registries. These registries must work
toward becoming a research resource for
epidemiology, molecular genetics, and pre-
vention studies. For example, studies of
gene-environment interaction in cancer eti-
ology must include population-based can-
cer familial and nonfamilial cancer cases.
The Cancer Prevention Research Registries
(CPRRs) outlined in Figure 2 are ideal for
such studies because they contain not only
family history information but also data on
host factors and environmental exposures as
well as linkage to a tissue bank. Existing
cancer registries around the United States
should be strengthened and other dimen-
sions added to their charge to augment
their function in prevention research.
Cancer registries, or the more compre-
hensive CPRRs, should also develop
research methods that analyze data beyond
the standard cancer rates by age, sex, race,
and ethnicity. These new methods should
be able to detect with high specificity and
sensitivity slight deviations from normal
patterns ofdisease in a general population
and associate such deviations with exoge-
nous exposures, host factors, or familial-
genetic predisposition. Thus, the CPRR
must register first-degree relatives of the
cancer patient, particularly for those cases
offamilial cancer to facilitate future research
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Figure 2. Components of a Cancer Prevention Research Registry(CPRR) and complementary databases.
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on gene-environment interaction. This
becomes especially important in the face of
the current explosion ofknowledge about
molecular biology and gene mapping.
As studies ofcancer turn increasingly to
molecular biology, genetic testing, and the
analysis ofgene-environmental interaction,
their psychosocial impact on family mem-
bers of cancer patients clearly becomes
important. Family members of cancer
patients who test positive constitute an
especially high and readily identifiable risk
group. Plans must be formulated now to
reduce the adverse effects that family mem-
bers of cancer patients may suffer as a
result oftheir identification.
The primary goal ofthe CPRRs should
be to support cancer prevention research in
its widest sense. A limited number of
examples of CPRR functions include
a) studies to identify high-risk groups such
as population-based familial breast, ovary,
and colorectal cancers in relation to patient
risk factors and environmental exposures;
b) testing ofbiological markers, including
both germline and somatic mutations of
known genes to measure genetic and
environmental influence on cancer risk;
c) monitoring ofoutcome measures in pre-
vention research studies, including behav-
ioral risk factors, adoption of healthier
lifestyles, practicing early detection, and
trends in the stage at diagnosis; and
d) evaluation of the effectiveness ofearly
detection procedures in the population
such as the mammography and Pap smear
procedures, particularly in underserved and
minority groups.
Future trends in cancer prevention
research should also include the under-
standing and use of information from two
sources: first, basic sciences laboratories
with regard to molecular biology and
cancer gene identification, mapping, and
gene characterization for specific tumors
and second, agencies setting the standards
for environmental exposure levels for car-
cinogenic agents (both single and mixed
exposures) in air, water, soil, and the home.
The information from these two sources,
together with data from the CPRRs, should
be applied in a hypothesis-driven fashion
to human populations but with wisdom
and with an understanding ofthe need to
protect the confidentiality ofthe individual.
Although the CPRR, as I have defined
it, is a more extensive collection of data
about the cancer patient and the family
than present population-based cancer reg-
istries, it cannot by itself be a sufficient
database for prevention research. The
CPRR must exist in association with a
number of other databases that provide
denominator data about the general popu-
lation in such terms as residential stability,
lifestyle characteristics, and cultural/socioe-
conomic status; information from environ-
mental monitoring networks; information
from health and risk factor surveys and
data on the availability of tissue banks;
input from health education, promotion,
and screening programs; and results from
population clinical trials.
Because the cause of cancer is most
frequently multifactorial, the effect of
exposure to multiple carcinogens may be
additive or synergistic. Thus, even though
the level of environmental exposure to a
particular carcinogen may be very small,
exposure to multiple small amounts may
be important and perhaps causative in
individuals already at a somewhat increased
risk for cancer because of other factors,
including genetic predisposition. In other
words, the addition of small amounts of
xenobiotic agents may be just sufficient to
reach the causative threshold. In a similar
fashion and, again, because of cancer's
multifactorial nature, the effect ofprotec-
tive or anti-carcinogenic agents must simi-
larly be additive or synergistic. Further,
there must be an equilibrium between the
level of genetic susceptibility and the
effects ofcarcinogens on the one hand and
protective agents in the external environ-
ment and in the human body on the other
that regulates cancer outcome. Future
research needs to be designed to investigate
each of the components of this model as
well as its integrated performance to more
successfully design and implement preven-
tion. Regardless of what we do in the
future, we must now promote healthier
lifestyles, prevent exposure to known
carcinogens, and improve early detection.
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